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ABSTRACT  
 Halogenated pyrroles (halopyrroles) are common chemical moieties found in bioactive bacterial natural 
products. The halopyrrole moieties of mono- and di- halopyrrole-containing compounds arise from a conserved 
mechanism in which a proline-derived pyrrolyl group bound to a carrier protein is first halogenated then 
elaborated by peptidic or polyketide extensions. This paradigm is broken during the marine pseudoalteromonad 
bacterial biosynthesis of the coral larval settlement cue tetrabromopyrrole (1), which arises from the substitution 
of the proline-derived carboxylate by a bromine atom. To understand the molecular basis for decarboxylative 
bromination in the biosynthesis of 1, we sequenced two Pseudoalteromonas genomes and identified a 
conserved four-gene locus encoding the enzymes involved its complete biosynthesis. Through total in vitro 
reconstitution of the biosynthesis of 1 using purified enzymes and biochemical interrogation of individual 
biochemical steps, we show that all four bromine atoms in 1 are installed by the action of a single flavin-
dependent halogenase- Bmp2. Tetrabromination of the pyrrole induces a thioesterase-mediated offloading 
reaction from the carrier protein and activates the biosynthetic intermediate for decarboxylation. Insights into 
the tetrabrominating activity of Bmp2 were obtained from the high-resolution crystal structure of the halogenase 
contrasted against structurally homologous halogenase Mpy16 that forms only a dihalogenated pyrrole in 
marinopyrrole biosynthesis. Structure-guided mutagenesis of the proposed substrate-binding pocket of Bmp2 
led to a reduction in the degree of halogenation catalyzed. Our study provides a biogenetic basis for the 
biosynthesis of 1, and sets a firm foundation for querying the biosynthetic potential for the production of 1 in 
marine (meta)genomes. 
 
SIGNIFICANCE STATEMENT 
The majority of pharmaceuticals are inspired by natural product scaffolds that are functionalized by 
tailoring enzymes, such as halogenases. Degree of halogenation is an important determinant of natural product 
bioactivity, yet little is known regarding the molecular basis for the exquisite control exhibited by tailoring 
halogenases. Known pyrrole halogenases commonly perform up to two halogenations on the pyrrole. Our study 
of tetrabromopyrrole biosynthesis revealed a uniquely adapted halogenase-thioesterase enzyme pair that 
catalyzes an unprecedented series of halogenations on a pyrrole. Structural comparison of the pyrrole 
tetrahalogenase to a pyrrole dihalogenase revealed key residues involved in controlling degree of halogenation. 
Our findings provide fundamental insights that might be applied in the rational design of biocatalysts toward 
directed biosynthesis of new chemicals.  
 
  
\body 
INTRODUCTION 
Marine bacteria of the genus Pseudoalteromonas produce numerous small molecule natural products 
with varied roles in marine chemical ecology (1-4). Recently, tetrabromopyrrole (1, Fig. 1) was established as a 
chemical cue produced by Pseudoalteromonas that induces larval settlement and metamorphosis in reef-
building Caribbean coral species (3). Additionally, the chemical structure of  1 is notable for its degree of 
halogenation (one-to-one carbon to halogen ratio), unique among naturally occurring aromatic organohalogens 
(5).  
 
Halopyrrole-containing microbial natural products are biosynthesized starting from L-proline. A highly 
conserved halopyrrole biosynthetic route involves oxidation of an acyl carrier protein (ACP)-loaded prolyl side 
chain and subsequent halogenation by a flavin-dependent halogenase (Fig. 1) (6). At this stage, two biosynthetic 
routes are possible. In the first route, the ACP-loaded halopyrrole is extended using modular assembly lines to 
yield non-ribosomally synthesized peptide, or polyketide natural products (e.g., 2–4, Fig. 1) (7-10). During the 
biosynthesis of 2–4, and other related natural products, the halopyrrole carboxylic acid is transthioesterified to 
downstream ACPs during modular elongation reactions. Molecules arising from these modular biosynthetic 
pipelines are characterized by the preservation of the prolyl alpha-carboxyl carbon atom as a carbonyl, or 
embedded in the final natural product skeleton in varying oxidation states (in red, Fig. 1). In a recently 
discovered alternate route, the prolyl alpha-carboxyl carbon atom is lost during the biosynthesis of 1 and the 
cytotoxic marine bacterial natural product pentabromopseudilin (5, Fig. 1) (4, 11). Uniquely, 5 is 
biosynthesized via the coupling of 2,3,4-tribromopyrrole (6, Fig. 1) to 2,4-dibromophenol rather than via a 
modular assembly line. The molecular mechanism for the pyrrole offloading from the ACP and elimination of 
prolyl alpha-carboxyl carbon en route the biosyntheses of 1 and 5–6 has not been determined. The structure of 1 
poses an additional biosynthetic challenge due to the presence of a bromine atom in place of an acyl side chain. 
While all previously described pyrrole halogenases catalyze one, two, or three halogen additions upon the ACP-
loaded pyrrole ring, a halogenase capable of four halogenations on the pyrrole ring, as implied by the structure 
of 1, has not been characterized. These open biosynthetic questions, together with the ecological significance of 
1 in coral larval settlement, motivated us to explore the genetic and molecular logic for its biosynthesis in 
marine bacteria. 
 
Herein, we establish the biosynthesis of 1 by the total in vitro enzymatic reconstitution of its 
biosynthetic machinery. We show that a single flavin-dependent brominase installs an unprecedented four 
halogens on an ACP-bound pyrrole required for the progression of thioesterase (TE)-mediated offloading and 
decarboxylation reactions. We also exploit an opportunity to structurally characterize and investigate via site-
directed mutagenesis the molecular basis for differential number of halogen additions catalyzed by flavin-
dependent halogenases on aromatic substrates. Our structural comparison of a highly homologous pyrrole 
dihalogenase to the pyrrole tetrahalogenase reveals subtle variations in biocatalyst design that lead to divergent 
molecular outcomes.   
 
RESULTS 
Genetic basis for the biosynthesis of 1  
We recently reported that 1 produced by the marine bacterium Pseudoalteromonas sp. PS5 induces 
settlement of larvae associated with several Caribbean coral species (3). To investigate the genetic basis for the 
biosynthesis of 1, we sequenced and assembled a 5.08 Mbp draft genome for P. sp. PS5. Querying the draft 
genome for the presence of the halopyrrole biosynthetic genes, we identified a gene locus in P. sp. PS5 with 
high homology to a subset of bromopyrrole biosynthetic genes present in the previously reported bmp gene 
locus from marine bacteria of the genera Pseudoalteromonas and Marinomonas (11) (Fig. 2A, Table S1). The 
organization of the bmp homologs identified in the genome of P. sp. PS5 (PS5_bmp) is identical to that of the 
bmp gene cluster found in Marinomonas mediterranea MMB-1 bmp (Mm_bmp) and others (11). Notably, the 
PS5_bmp gene locus maintains the bromopyrrole biosynthetic module Mm_bmp1–4 and the 
bromopyrrole/phenol coupling cytochrome P450 (CYP450) accessory genes Mm_bmp9–10, but lacks the genes 
associated with bromophenol biosynthesis (Mm_bmp5–6) and the CYP450-Mm_bmp7 (Fig. 2A). In addition, 
we also sequenced and assembled a 5.13 Mbp draft genome for Pseudoalteromonas sp. A757 that also produces 
1 (12). Querying the genome of P. sp. PS5 as before revealed a gene cluster with high homology to PS5_bmp 
(A757_bmp), providing a second example of a stand-alone bromopyrrole biosynthetic pathway from the genus 
Pseudoalteromonas (Fig. 2A, Table S1) 
  
To evaluate the role of PS5_bmp1–4 genes in the production of 1, we cloned and heterologously 
expressed PS5_bmp1–4 in Escherichia coli. Only in the presence of bromide in the culture media, we observed 
robust heterologous production of 1 along with a minor amount of 6, consistent with the product profile 
observed in organic extracts of cultures of P. sp. PS5 and P. sp. A757 (Fig. 2B). While these results 
demonstrate that bmp1–4 genes are necessary for the production of 1, the molecular detail underlying the 
offloading of the L-proline derived pyrrole moiety from the ACP, its timing relative to the bromination events, 
and the chemical logic for the loss of L-proline derived alpha-carboxyl was not discernible at this stage. Hence, 
we next examined the biosynthetic pathway by total in vitro enzymatic reconstitution of the production of 1 
using purified enzyme catalysts. 
 
Decarboxylative bromination of thiotemplated pyrrole 
 In order to examine the individual roles of Bmp1–4, we performed the total in vitro reconstitution of the 
biosynthesis of 1 (Fig. 3A). Due to high sequence similarity of PS5_Bmp1–4 to Mm_Bmp1–4 (Table S1), and 
production of 1 by both P. sp PS5 and M. mediterranea MMB-1 (11), we used recombinant Mm_Bmp1–4 
proteins in our in vitro investigations. Bmp2 and Bmp4 were individually purified as N-His6-tagged proteins, 
while N-His6-tagged apo-Bmp1 was purified in complex with untagged Bmp3 and converted to its pantetheine-
loaded holo-form by the promiscuous Bacillus subtilis phosphopantetheinyl transferase Sfp (11, 13) (Fig. 3A. 
Incubation of L-proline and bromide with purified Bmp1–4 enzymes, along with flavin and nicotinamide 
cofactors (FAD and NADP+), and cofactor regeneration enzymes (PtdH and SsuE) led to the formation of 1 as 
the major product (Fig. 3; see SI Appendix, Fig. S1). The production of 1 was abolished in the absence of ATP, 
which is required for the loading of L-proline on to the ACP-domain of Bmp1 by Bmp4 (Fig. 3B). By 
comparison to authentic synthetic standards, we also confirmed the production of 6 and 3,4,5-tribromo-pyrrole-
2-carboxylic acid (7) as minor products of the reaction (Fig. 3B). 
  
Having established that Bmp1–4 enzymes are sufficient for the production of 1, we next queried the 
timing and mechanism of the terminal bromination, offloading, and decarboxylation reactions. We previously 
established that Mm_Bmp2 converts pyrrolyl-S-Bmp1(ACP) to tribromopyrrolyl-S-Bmp1(ACP) (Fig. 3A), 
where the Bmp1(ACP) domain comprises residues 1–77 of Bmp1 (11). Hence, we rationalized that 3,4,5-
tribromopyrrolyl-S-Bmp1(ACP) (8, Fig. 4A) might be an intermediate en route to 1. To test this hypothesis, we 
synthesized 8 following a recently described chemoenzymatic method (14). Briefly, synthetic 7, generated by 
the bromination of pyrrole-2-carboxylic acid, was sequentially ligated to cysteamine and then to pantothenic 
acid to afford 3,4,5-tribromopyrrolyl-S-pantetheine 9 (Fig. 4A, see Supporting Information for synthesis 
protocols and product characterization data). Compound 9 was then extended by the E. coli coenzyme A (CoA) 
biosynthetic enzymes CoaA, CoaD, and CoaE to generate 3,4,5-tribromopyrrolyl-S-CoA, that was used as the 
substrate for the in situ transfer of the 3,4,5-tribromopyrrolyl-S-phosphopantetheine moiety to the serine side 
chain hydroxyl of apo-Bmp1(ACP) by Sfp to yield 8 (Fig. 4A; see SI Appendix, Fig. S2). We then expressed 
and purified the Bmp1 thioesterase domain, Bmp1(TE), whose activity we previously confirmed using a model 
esterase substrate- p-nitrophenylacetate (11). Incubation of 8 with Bmp2, Bmp1(TE), bromide, NADP+, FAD, 
and cofactor regeneration components led to formation of 1 as the major product, together with minor 
production of 6 and 7 (Fig. 4B, Figs. S1). Exclusion of Bmp1(TE)  from the reaction led to trace production of 
1 (Fig. 4B). Additionally, we mapped the active site serine residue of Bmp1(TE) to Ser202 and confirmed that 
its mutation to alanine resulted in loss of esterase activity for the p-nitrophenylacetate substrate (see SI 
Appendix, Fig. S3). Substitution of Bmp1(TE) with catalytically inactive Bmp1(TE)S202A mutant enzyme led 
to significantly reduced production of 1 (Fig. 4B; see SI Appendix, Fig. S4). Finally, exclusion of Bmp2 from 
the reaction completely abolished the production of 1 (Fig. 4B; see SI Appendix, Fig. S4). Similar levels of 7 
were observed across all reactions, suggesting that it is likely an ‘off-pathway’ product resulting from the 
hydrolysis of 8 (Fig. 4B). In support of 7 as a hydrolytic shunt product, no conversion of 7 to 1 or 6, or to any 
new products was observed upon its incubation with Bmp2, Bmp1(TE) and bromide (see SI Appendix, Fig. S5). 
These results provide two important findings. First, both catalysts, Bmp1(TE), and the halogenase Bmp2 are 
required to convert the intermediate 8 to 1. Second, two enzymatic activities, that is, hydrolysis via thioesterase 
Bmp1(TE) and bromination via Bmp2 lead to three chemical events – 1) offloading of the pyrrole from 
Bmp1(ACP), 2) the fourth bromination on the 2’-position of the pyrrole, and 3) decarboxylative loss of the L-
proline derived alpha-carboxylate carbon atom. 
 
We next evaluated the timing of formation of 6 relative to the formation of 1. We thus incubated 6 with 
Bmp2, with and without Bmp1(TE), and cofactor-regenerating enzymes. We observed trace conversion of 6 to 
1 only after prolonged reaction times, consistent with our hypothesis that 6 is a non-physiological substrate for 
Bmp2 (see SI Appendix, Fig. S5). Hence, we propose that 6 might be a non-enzymatic reductive degradation 
byproduct of 1. Indeed, incubation of synthetically prepared 1 with NADPH led to the conversion to 6 at levels 
comparable to total in vitro reconstitution reactions (see SI Appendix, Fig. S6). Together with our previous 
results, we propose that 7 and 6 are both off-pathway products arising, respectively, at stages preceding and 
following formation of 1 (Fig. 5).  
 
In sum, our data support the Bmp2-catalyzed bromination of 8 leading to transient intermediate i as 
shown in Fig. 5, which would undergo transesterification to generate a Bmp1(TE)S202 side chain-bound 
oxoester ii, thus offloading the pyrrole from Bmp1(ACP). Hydrolytic offloading from the Bmp1(TE) would 
generate the labile alpha-bromo acid iii. Driven by the rearomatization of the pyrrole ring, iii would 
spontaneously decarboxylate to 1. Direct mass spectrometric evidence for i proved elusive, suggesting that i 
rapidly converts back to 8 via spontaneous debromination in the absence of Bmp1(TE). Hence, the role of the 
Bmp1(TE) could be to trap the tetrabrominated pyrrole species by means of an irreversible transesterification 
step, while the fourth bromination by Bmp2 activates the substrate for decarboxylation subsequent to hydrolytic 
offloading from Bmp1(TE). 
 
Non-enzymatic hydrolysis of i may also lead to release of iii to afford 1, consistent with our observation 
of low levels of 1 from reactions excluding Bmp1(TE) and with inactive Bmp1(TE)S202A. The observation of 
similar levels of 7 in all reactions further supports direct hydrolytic bypass of TE-mediated offloading. 
Furthermore, the fourth bromination of 8 by Bmp2, followed by transesterification and decarboxylation of i 
neatly differentiates the biosynthesis of 1 from non-ribosomal peptide synthetase and polyketide synthase 
derived pathways involving halopyrrole units in which the L-proline derived alpha-carboxylate carbon atom is 
preserved in the mature natural product (Fig. 1). 
 
 
Structural basis for unique tetrahalogenating activity of Bmp2 
To realize the scheme shown in Fig. 5, the flavin-dependent brominase Bmp2 would need to halogenate 
all four positions of the pyrrole ring. This mechanistic requirement for the production of 1 is in stark contrast to 
all previously characterized pyrrole halogenases that halogenate the pyrrole ring only once or twice. In order to 
understand the structural basis for the tetrahalogenating activity of Bmp2, we determined the high-resolution 
crystal structure of FAD-bound holo-Bmp2 at a limiting resolution of 1.87 Å (Fig. 6A) and compared it to the 
FAD-bound holo-structure of dihalogenase Mpy16 participating in the biosynthesis of 3 that we determined at 
1.95 Å resolution (Fig. 6B, Table S2) (8). Bmp2 and Myp16 structures are highly homologous with all 
secondary structural elements in the vicinity of the active site strictly conserved between the two enzymes (see 
SI Appendix, Fig. S7). Furthermore, the FAD cofactor isoalloxazine rings and the postulated active site lysine 
residues (15) (K74 for Bmp2, K72 for Mpy16, Fig. 6A,B) are superimposable. Though we could not determine 
a substrate pyrrolyl-S-ACP co-crystal structure for either Bmp2 or Mpy16, the position of the pyrrole binding 
sites for Bmp2 and Myp16 was inferred by a structural alignment of Bmp2 and Mpy16 with the crystal 
structures of substrate-bound forms of the flavin-dependent tryptophan-7-chlorinases PrnA (16) and RebH (17). 
Fittingly, the postulated pyrrole-binding site in Bmp2 and Mpy16 (Fig. 6A,B) is in close proximity to the side 
chain of the catalytic lysine residue. An examination of the amino acids lining this putative pyrrole binding site 
in Bmp2 reveals a lack of conservation of three key sites (Y302, F306, and A345) that are otherwise strictly 
conserved among all pyrrolyl-S-ACP halogenases that selectively catalyze one (HrmQ (10)) or two (PltA (7), 
Mpy16 (8), Clz5 (9), and Pyr29 (18)) halogenations on the pyrrole ring (Fig. 6D). We thus mutated these three 
residues in Bmp2 to the corresponding residues in Mpy16 (Fig. 6B) to generate Bmp2-Y302S/F306V/A345W 
triple mutant enzyme (henceforth referred to as Bmp2-TM). We next investigated the affect of the triple 
mutation on the in vivo heterologous production of 1 in E. coli. Co-expression of Mm_bmp1, Mm_bmp3, and 
Mm_bmp4, with Mm_bmp2-TM in E. coli led to a complete loss in the in vivo production of 1 in contrast to 
robust production with wild-type Mm_bmp2 (see SI Appendix, Fig. S9).  
 
To explore the molecular basis for the in vivo loss in production of 1 by the Bmp2-TM enzyme, we 
compared the in vitro enzymatic activities of Bmp2, Mpy16, and Bmp2-TM enzymes. We chemoenzymatically 
synthesized pyrrolyl-S-Bmp1(ACP) and pyrrolyl-S-Mpy15, the requisite substrates for Bmp2 and Mpy16, 
respectively (8, 11, 14). Using a previously reported mass spectrometry-based proteomic assay that relies on 
detection of acyl-(cyclo)pantetheine MS2 product ions (14), we verified that wild-type Bmp2 enzyme catalyzed 
three brominations on the pyrrole ring (Fig. 6E), and that Mpy16 catalyzed no more than two chlorinations on 
the pyrrole ring acylated to Mpy15 (Fig. 6F) (14). Note that although Bmp2 tetrabrominates the pyrrole ring as 
established by our previous findings, the assay employed here detects only up to tribromination of pyrrolyl-S-
Bmp1(ACP). In contrast to the wild-type Bmp2, Bmp2-TM could only catalyze a single bromination on the 
pyrrole ring (Fig. 6G; see SI Appendix, Fig. S8), thereby precluding the synthesis of 1. 
 
Lastly, to eliminate the possibility that the reduced degree of halogenation catalyzed by Bmp2-TM was 
due to disruption of the enzyme active site by the three mutations, we determined the crystal structure of holo-
Bmp2-TM at a resolution of 1.98 Å (Fig. 6C). Structural comparison of Bmp2-TM to Bmp2 and Mpy16, 
confirmed that the mutation of the three Bmp2 active site residues did not alter the positioning of the FAD 
isoalloxazine ring or the catalytic lysine side chain. 
 
DISCUSSION 
In addition to characterizing the biosynthesis of a microbially produced coral settlement cue, our study 
reveals novel enzymology stemming from a biosynthetic motif ubiquitous among halopyrrole-containing 
natural products. While our previous work had established tribromination of pyrrolyl-S-Bmp1(ACP) by Bmp2, 
the enzymatic activities responsible for the addition of the fourth bromine atom in 1 and offloading and 
decarboxylation of the pyrrolyl moiety from the ACP were unknown (11). Our current work demonstrates that a 
single halogenase, Bmp2, catalyzes the unprecedented tetrabromination of the ACP-bound pyrrole, which 
subsequently undergoes Bmp1(TE)-mediated offloading from the ACP and spontaneous decarboxylation. In 
light of the elucidation of the molecular and genetic details for the construction of 1, we posit 1 is an 
intermediate en route to the production of 5, reconciling a previous report implicating a L-proline-derived 
symmetrical pyrrolic intermediate in the biosynthetic scheme for the production of 5 (19). Previously, based on 
primary sequence homology, we postulated that the enzyme Bmp8 (Fig. 2A) participates in the decarboxylation 
of 7 to produce 6 (11), a hypothetical route that is likely not operative in light of the biochemical data presented 
above. Hence, the physiological transformations for the production of 6 en route 5 remain to be elucidated. 
Furthermore, the previously reported production of 1 during the CYP450-Bmp7 mediated biradical 
homodimerization of 6 is likely an off-pathway route, with Bmp1–4 being the primary players in the production 
of 1. Successive biochemical studies promise to address these open questions to characterize all steps in the 
biosynthesis of 5 and assign physiological roles for each of the Bmp enzymes. 
 
The complete in vitro reconstitution of the production of 1 using purified enzyme catalysts suggests a 
mechanism for the acyl-phosphopantetheine thioester to be sequestered and thereby inaccessible to Bmp1(TE) 
until the terminal fourth bromination. Sequestration of a pyrrole tethered to a type II peptidyl carrier protein 
(PCP) was recently demonstrated for a highly homologous PCP-PltL (57% amino acid similarity to 
Mm_Bmp1(ACP)) participating in the biosynthesis of the dichloropyrrole-containing natural product 
pyoluteorin (7, 20). By analogy, in the biosynthesis of 1, it is possible that the terminal halogenation on the 
pyrrole partially liberates the sequestered substrate from the ACP, allowing access to the thioesterase. Hence, 
the terminal fourth bromination by Bmp2 serves the dual role of triggering the release of the sequestered pyrrole 
moiety by presumably making the thioester susceptible to hydrolysis, in addition to activating the substrate for 
elimination of the L-proline derived alpha-carboxyl. Activating halogenation reactions in natural product 
biosynthetic pathways have been demonstrated in the biosynthesis of NRPS-PKS hybrid curacin A, in which a 
cryptic halogenation catalyzed by α-ketoglutarate-dependent halogenase-CurA promotes cyclopropane ring 
formation (21), and in the biosynthesis of meroterpenoid merochlorins A and B, in which a 
dearomatization/terpene cyclization reaction cascade is initiated by a chlorination catalyzed by vanadium-
dependent haloperoxidase- Mcl24 (22). Most analogously, paralleling the decarboxylative bromination strategy 
employed by Bmp2, flavin-dependent brominase- Bmp5 catalyzes a bromination reaction that drives 
decarboxylation in the conversion of free p-hydroxybenzoic acid to 2,4-dibromophenol, the bromophenol 
building block of 5 (11).  
 
The tetrabromination activity of Bmp2 is unprecedented among the numerous flavin-dependent 
halogenases described to date in the natural product literature that selectively add a specific number of halogen 
atoms to an aromatic substrate. In this study, we embraced the opportunity to interrogate the structural basis for 
this halogenation control in flavin-dependent pyrrolyl-S-ACP halogenases, in the process determining the first 
crystal structures of biochemically characterized flavin-dependent halogenases acting on ACP-bound 
substrates. While the previously reported 2.1 Å crystal structure of putative tyrosyl-S-ACP flavin-dependent 
halogenase CndH highlighted the general differences in the architectures of flavin-dependent halogenases acting 
on free versus ACP-bound substrates (23), our study sheds mechanistic insight into the tuning of the enzyme 
active site in the context of confirmed biochemistry. Comparison of the putative substrate-binding cavities of 
the highly conserved structures of Bmp2 and Mpy16 resulted in a catalyst, Bmp2-TM, exhibiting an altered 
halogenation profile. Notably, the active site of Bmp2-TM exhibited no perturbation of the bound FAD co-
factor with respect to wild-type Bmp2, nor did it lead to any apparent change in halogen binding properties of 
the enzyme, as demonstrated by conservation of its specificity for bromide. Already, for flavin-dependent 
tryptophan halogenases, it has been demonstrated that amino acid side chains that constitute the substrate 
binding site control the regiochemical outcomes for halogen additions (17, 24-25). Our findings extend this 
observation to flavin-dependent halogenases that catalyze halogenation of aromatic substrates acylated to ACPs 
in demonstrating that side chains of residues lining the putative halogenase active site play a role in controlling 
substrate access, and potentially in specifying the positions on the pyrrole ring that are accessible to 
halogenation. Unfortunately, in the case of Mpy16, efforts to alter the putative substrate-binding cavity to 
resemble that of Bmp2 resulted in insolubility of the mutant Mpy16 enzymes. Nonetheless, our results 
demonstrate that the active sites of otherwise highly homologous flavin-dependent halogenases are uniquely 
evolved to afford distinct product profiles. Biological activities of natural products are influenced by the number 
of halogens decorating their organic scaffolds (26-27), and it would appear that Nature has taken note through 
the evolution of highly specialized halogenation catalysts.  
 
In light of the existing literature and the findings of this study, several open questions remain regarding 
enzymatic halogenation (28). Of note is the question of the binding mode of both the ACP and the aromatic 
substrate by flavin-dependent halogenases that require acyl-S-ACP substrates. In addition, the primary question 
across all classes of halogenating enzymes is the structural determinant for halide specificity among these 
catalysts. While Bmp2 and Mpy16 demonstrate different halide specificities, the amino acid side chains and the 
positioning of the FAD isoalloxazine ring relative to these side chains is remarkably conserved. Furthermore, 
the conservation of halide specificity in Bmp2-TM with respect to the WT enzyme raises the possibility that 
halide specificity in flavin-dependent halogenases is dictated not only by steric factors such as halide ion radii, 
but also by the magnitude of the enthalpic penalty associated with desolvation of the halide ion in the 
halogenase active site prior to 2e- oxidation to generate the electrophilic halonium. Furthermore, the 
contribution of the redox potential of the flavin isoalloxazine ring necessary to oxidize the halide, and the 
stability of the activated lysine-amine intermediate generated en route to transfer of the halonium to the 
aromatic substrate should be considered (15). As such, the currently proposed halide binding site for flavin-
dependent halogenases is itself debatable (29), thus underscoring the challenges associated with teasing apart 
the role of the enzymatic halogenase catalyst in each of the requisite mechanistic steps. Discovery and 
characterization of additional flavin-dependent halogenases promises to provide opportunities to answer these 
mechanistic questions, ultimately leading to engineer-able toolkits to tailor the biosynthesis of halogenated 
natural products (30).  
 
 
MATERIALS AND METHODS 
Detailed materials and methods are provided in the SI Materials and Methods.  
 
Database deposition information 
The sequences for P. sp. PS5 and P. sp. A757 derived bmp gene clusters are deposited in GenBank 
under accession numbers KR011923 and KT808878, respectively. Structures for Mpy16, Bmp2, and Bmp2-TM 
are deposited in the Protein Data Bank (www.rcsb.org) under accession numbers 5BUK, 5BVA, and 5BUL, 
respectively.  
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MAIN TEXT FIGURES & LEGENDS 
 
Fig. 1. Structures and biosynthesis of halopyrrole natural products. Halopyrrole biosynthesis starts from the 
loading of L-proline on to an ACP phosphopantetheine thiol by an adenylation (A) enzyme, followed by a 4e- 
oxidation of the prolyl ring to a pyrrole (in blue) catalyzed by a dehydrogenase (DH) enzyme. Subsequent 
halogenation by a flavin-dependent halogenase (Hal) then installs one, two, or three halogens on the pyrrole 
ring. At this stage, the thiotemplated halopyrrole can proceed down assembly line biosynthetic routes to afford 
natural products such as hormaomycin (2), marinopyrrole A (3), and chlorizidine (4) (8-10). However, the 
biosyntheses of 1 and 5–6 do not entail modular assembly line extension of the L-proline-derived halopyrrole, 
but rather involve the loss of the prolyl alpha-carboxylate carbon atom (in red) via an unexplained mechanism.  
 
Fig. 2. A genetic basis for production of 1. (A) Mm_bmp, PS5_bmp, and A757_bmp gene clusters with 
bromopyrrole and bromophenol biosynthetic genes indicated below the Mm_bmp gene cluster; a putative 
permease (uncolored) is inserted between Mm_bmp3 and Mm_bmp4. Mm_Bmp1–4 are colored per their 
catalytic roles shown in Fig. 1. Note that bmp1 encodes a di-domain protein with an ACP domain at the N-
terminus followed by a TE domain (11). (B) LC/MS extracted ion chromatograms (EICs) for [M-H]1- ions 
corresponding to 1 and 6 in organic extracts of P. sp. PS5, P. sp. A757, and E. coli expressing PS5_bmp1–4 
grown in media with (+) or without (-) bromide.  
 
Fig. 3. Enzymatic synthesis of 1. (A) Scheme for the total in vitro enzymatic synthesis of 1 starting from L-
proline. Accessory enzymes not derived from the Mm_bmp gene cluster are indicated in red. FADH2 required as 
a cofactor for Bmp2 was regenerated in situ by E. coli flavin reductase SsuE (32) which in turn oxidizes 
NADPH to NADP+. NADP+ was recycled to NADPH in situ using NAD(P)+ reductase/phosphite 
dehydrogenase- PtdH  (33). (B) EICs for [M-H]1- ions corresponding to 1, 6, and 7 for organic extracts of 
reactions described in panel A. Note that the production of 1, 6, and 7 was abolished in the absence of ATP. 
 
 
Fig. 4. Preparation of 8 and in vitro conversion to 1 by Bmp2 and Bmp1(TE). (A) Scheme showing 
generation of 8 by one-pot in vitro extension of synthetically prepared 9 using E. coli CoA biosynthetic 
enzymes, and loading onto holo-Bmp1(ACP) by Sfp. (B) Scheme for conversion of 8 to 1, 6, and 7 by Bmp2 
and Bmp1(TE). Omitted for clarity are the cofactor regeneration systems for Bmp2 shown in Fig. 3. Only trace, 
or no production of 1 was observed when either Bmp2 or Bmp1(TE) were omitted from the in vitro enzymatic 
reaction, or when the catalytically inactive Bmp1(TE)S202A enzyme was used.  
 Fig. 5. Scheme for bromination-dependent pyrrole offloading and decarboxylation. Proposed reaction 
mechanisms for terminal bromination, offloading, and decarboxylation reactions with 8; inferred intermediates 
are indicated by bold Roman numerals.  
 
Fig. 6. Structural basis for tetrahalogenation activity of Bmp2. Comparison of the active sites of (A) holo-
Bmp2, (B) holo-Mpy16, and (C) holo-Bmp2-TM. Note that side chains of Bmp2-TM residues S302, V306, and 
W345 in panel C structurally map to the corresponding side chains of Mpy16 residues S325, V329, and W369 
shown in panel B without perturbation of the FAD isoalloxazine ring or the proposed catalytic lysine side chain. 
(D) Primary sequence alignments of tetrahalogenase Bmp2 with mono- and di- halogenating pyrrolyl-S-ACP 
halogenases demonstrates that the amino acids that were mutated on the basis of structural comparison to form 
Bmp2-TM (indicated by ▲) are strictly conserved in all pyrrolyl-S-ACP halogenases but Bmp2 (see SI 
Appendix, Fig. S20 for alignment of Bmp2 homologs from different bacterial species). EICs for acyl-
(cyclo)pantetheine MS2 product ions demonstrate that (E) wild type Bmp2 generates mono-, di- and tri- 
bromopyrrolyl-S-Bmp1(ACP) products, while (F) Mpy16 generates only mono- and di-chloropyrrolyl-S-
Mpy15, and (G) Bmp2-TM generates only mono-bromopyrrolyl-S-Bmp1(ACP) product. 
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MATERIALS AND METHODS 
Genome sequencing  
 Genomic DNA was isolated from 5 mL overnight liquid cultures of P. sp. PS5 and P. sp. A757 
inoculated in 5 mL Difco 2216 Marine Broth (BD 212185) from -80 ºC glycerol stocks and grown overnight at 
30 ºC with shaking at 200 rpm. Genomic DNA was isolated using a DNeasy Blood & Tissue Kit (Qiagen) 
following the spin column protocol for extraction of genomic DNA from gram-negative bacteria. Next 
generation sequencing libraries were constructed from genomic DNA of P. sp. PS5 and P. sp. A757 using the 
Ion PGM Template OT2 400 bp Library Preparation Kit (Life Technologies). The library was sequenced on an 
Ion Torrent PGM platform (Life Technologies) using an Ion Torrent 318v2 sequencing chip (Life 
Technologies).  
 
Genome assembly, annotation and verification of Bmp genes 
 De novo assemblies of raw reads of P. sp. PS5 and P. sp. A757 were performed using CLC Genomics 
Workbench (Qiagen) and SPAdes (1) assemblers, respectively, using default parameters for Ion Torrent PGM 
sequencing. Annotation of the draft genomes of P. sp. PS5 and P. sp. A757 was performed using the RAST 
server (2). The draft genome was queried with translated sequences of Mm_Bmp1–10 using BLAST in the 
SEED Viewer genome browser interface. PS5_bmp and A757_bmp gene sequences were verified by Sanger 
sequencing (SeqXcel, La Jolla, CA). 
 
Cloning and heterologous expression of PS5_bmp1–4 
 PS5_bmp1–4 was PCR amplified from genomic DNA using PrimeStar Max DNA polymerase (Takara) 
standard protocol, and ligated into SacI/NotI (NEB) digested pETDuet (Novagen) using T4 DNA Ligase (NEB), 
followed by propagation in E. coli DH5α (NEB), Qiagen MiniPrep plasmid extraction, and Sanger sequencing 
verification (SeqXcel, La Jolla, CA). An open reading frame encoding an ACP synthase (AcpS) from M. 
mediterranea (3) (Genbank accession code: NC_015276.1) was amplified from genomic DNA and cloned into 
NdeI/XhoI digested pRSFDuet (Novagen) using the same protocol as before. Thus constructed pETduet-PS5-
_bmp1–4 and pRSFduet-acpS were co-transformed into E. coli BL21-Gold(DE3) (Agilent) for expression. Five 
mL LB containing 50 µg/mL kanamycin and 100 µg/mL carbenicillin to maintain plasmids with and without 1 
g/L KBr (final concentration) were each inoculated with 100 µL of overnight culture of E. coli BL21-
Gold(DE3)/pETDuet-PS5_bmp1–4/pRSF-acpS grown at 30 ºC. The cultures were grown at 37ºC for 2 h with 
shaking, then transferred to 30 ºC and induced after 15 min with 50 µM IPTG (final concentration). Cultures 
were incubated for an additional 16 h at 30 ºC with shaking at 200 rpm. Cultures were subsequently extracted 
with two volumes of EtOAc. The organic layer was collected and solvent was removed in vacuo. The resulting 
residue was dissolved in 100 µL MeOH for LC/MS/MS analysis.    
 
Analytical scale culturing and extraction of wildtype tetrabromopyrrole-producing bacterial strains 
 P. sp. PS5 and P. sp. A757 were cultured as previously described (4-5). Briefly, a Difco 2216 Marine 
Broth (BD 212185)/agar plates were inoculated from a -80 ºC glycerol stocks of P. sp. PS5 or P. sp. A757 and 
grown overnight at 30 ºC. Five mL Difco 2216 liquid broth were inoculated with a single colonies of P. sp. PS5 
or P. sp. A757 and grown overnight at 30 ºC with shaking at 200 rpm. Fifteen mL Difco 2216 liquid broth 
supplemented with an additional 1 g/L KBr (final concentration) to increase production of brominated 
secondary metabolites (6) were inoculated with 100 µl of overnight cultures and incubated overnight at 30 ºC 
with shaking at 200 rpm. The cultures were subsequently extracted with two volumes of EtOAc. The organic 
layers were collected, and the solvent was removed in vacuo. The residues were dissolved in 100 µL MeOH 
each for LC/MS/MS analysis.  
 
LC/MS/MS elution profile used for analysis of in vivo and in vitro extracts  
 Extracts were analyzed by LC/MS/MS using a reverse phase C18 column (Phenomenex Luna, 5 µm, 4.6 
× 100 mm) operating on an Agilent 1260 HPLC in tandem to an Agilent 6530 Accurate Mass Q-TOF mass 
spectrometer. Mass spectra were acquired in negative ionization mode. Data was acquired for blank runs 
between samples to prevent and exclude carry-over of bromopyrroles from one sample to the next. HPLC 
solvents used were water + 0.1 % formic acid (A) and MeCN + 0.1 % formic acid (B). The HPLC elution 
profile was as follows: (initial flow rate 0.5 mL/min) 10% B for 5 min, linear gradient to 70% B over 10 min, 
linear increase to 80% B over 10 min, (flow rate changed to 0.7 mL/min) linear increase to 100% B over 0.5 
min, hold at 100% B for 3 min, linear decrease to 10% B over 0.5 min. Identical injection volumes were used 
within a given experiment.  
 
Data analysis and plotting  
 LC/MS/MS data was analyzed using the Agilent MassHunter software package. Data was plotted using 
Microsoft Excel and OriginPro (OriginLab). Extracted ion chromatograms were called using the [M-H]1- ± m/z 
0.5 for the most abundant isotope as follows: 1 (m/z 381.67), 6 (m/z 301.76), and 7 (m/z 345.75). 
Chromatograms corresponding to sets of experiments (i.e., within a given figure panel) are normalized to the 
largest peak among spectra, while individual chromatograms are normalized to the largest peak within that 
chromatogram.  
 
Cloning, protein expression and purification for in vitro assays 
Cloning and expression of Mm_Bmp1-Bmp3 complex, Mm_Bmp2, Mm_Bmp4, Mm_Bmp1(ACP), and 
Mm_Bmp1(TE) were performed in a manner identical to previously reported (3). B. subtilis Sfp and P. stutzeri 
PtdH were also purified in an identical to that previously described (3). Expression of E. coli SsuE was 
performed according to a published protocol (7).  
Mm_Bmp1(TE):S202A is new to this study, and was purified in an identical manner to that reported for 
wildtype recombinant proteins (3). Point mutagenesis of Mm_bmp1(TE) to generate the Ser202 to Ala mutant 
was performed by PCR mutagenesis using PrimeStar Max DNA Polymerase (Takara)  standard protocol with 
pET28-N-His6-Mm_bmp1(TE) as the template. Primers were designed with the motif 5′-[20 nucleotide 
sequence-modified overlap] [35 nucleotide primer region]-3′ followed by treatment with DpnI exonuclease, 
propagations in E. coli DH5α (NEB), Sanger sequencing verification (SeqXcel, La Jolla, CA), and 
transformation into E. coli Bl21-Gold(DE3) (Agilent) for expression. 
 
Total in vitro enzymatic synthesis of 1 from L-proline 
 One mL reactions consisting 2 mM L-proline, 0.5 mM CoA, 2 mM MgCl2, 50 mM KBr, 2 mM NADP+, 
0.1 mM FAD, 10 mM phosphite, 10 µM Mm_Bmp1-Bmp3 complex, 25 µM Mm_Bmp2, 1 µM Mm_Bmp4, 2 
µM Sfp, SsuE, and PtdH were incubated for 12 h at 30 ºC with and without ATP in buffer consisting of 20 mM 
Tris-HCl (pH 8), 50 mM KCl, 10 % (v/v) glycerol. Reactions were extracted with 1.6 mL EtOAc. The organic 
layer was collected and solvent was removed in vacuo. The resulting residue was dissolved in 100 µL MeOH, 
and 30 µL were injected for LC/MS/MS analysis in the same manner as described for analysis of in vivo 
extracts.  
 
Chemical synthesis 
Chemicals and solvents. All chemicals were purchased from Acros, Aldrich, Fluka, or Alfa Aesar and 
used as such unless stated otherwise. For flash chromatography technical grade solvents were used without 
further purification. For reactions analytical grade solvents were purchased and used without further 
purification. Deuterated solvents were obtained from Sigma-Aldrich.  
Reactions. All non-aqueous reactions were carried out using oven-dried glassware under an atmosphere 
of nitrogen unless otherwise stated. Reactions were magnetically stirred and monitored by TLC unless 
otherwise stated. Chromatographic purification was performed as flash chromatography (Alfa Aesar silica gel, 
60 Å pore size) using the solvents indicated as eluent with 0.3-0.5 bar pressure. Thin layer chromatography 
(TLC) was performed on Merck silica gel 60 F254 TLC glass plates and visualized with UV light or stained in 
ceric ammonium molybdate or potassium permanganate solutions. The yields given refer to 
chromatographically purified and spectroscopically pure compounds unless otherwise stated.  
Analysis. 1H- and 13C- NMR spectra were recorded on VARIAN Inova (500 MHz) or BRUKER Avance 
(600 MHz) spectrometers in the solvents indicated. All signals are reported in ppm with the internal chloroform 
signal at 7.26 ppm or 77.0 ppm, or the internal DMSO signal at 2.50 ppm or 39.52 ppm as standard. The data is 
being reported as (s=singlet, d=doublet, t=triplet, q=quadruplet, m=multiplet or unresolved, br=broad signal, 
coupling constant(s) in Hz, integration). HiRes-MS was carried out on an Agilent 1100 Series Instrument with 
diode-array and MS detectors on a Phenomenex Luna C18 5μ 100 x 4.6 mm column.  
 
Chemical syntheses of 1, 6, and 7 
 Synthetic standards of 1, 6, and 7 were prepared according to reported protocols. 1 was prepared 
according to literature procedures by halogenation of pyrrole using NBS (8). 2,3,4-tribromo-1H-pyrrole 6 was 
prepared according to a modified literature procedure (9). For the TIPS protection of pyrrole, sodium hydride 
was employed as a base instead of n-BuLi. 7 was prepared according to a slightly modified literature procedure 
(10): To a suspension of pyrrole-2-carboxylic acid (1g, 9 mmol) in CHCl3 (10 mL) and AcOH (2 mL) was 
slowly added bromine (1.6 mL, 31.5 mmol). The reaction was warmed to 50 °C and stirred for 4 h. The mixture 
was diluted with CHCl3 and water. The phases were separated and the organic phase was washed with water. 
The carboxylic acid was then extracted from the organic phase using 10% K2CO3. The basic solution was first 
washed twice with CHCl3 and then acidified using 4M HCl. The resulting precipitate was collected by filtration 
and dried under vacuum to give 7. 1: 1H-NMR (500 MHz, CDCl3, for full spectrum see Fig. S10): δ 8.52 (bs, 
1H, NH); HRMS (ESI) m/z calculated for C4NBr4 ([M-H]1-) 377.6770, found 377.6759. 6: 1H-NMR (600 MHz, 
CDCl3, values in good agreement with literature (11)): δ 8.46 (bs, 1H, NH), 6.86 (d, J = 3.1 Hz, 1H); HRMS 
(ESI) m/z calculated for C4NBr3 ([M-H]-) 299.7665, found 299.7663. 7: (300 mg, 0.86 mmol, 10%). Rf 0.15 
(hexanes/EtOAc 4:1); 1H-NMR (500 MHz, d6-DMSO, for full spectrum see Fig. S11): δ 12.97 (bs, 1H, 
COOH), 11.71 (bs, 1H, NH); 13C-NMR (150 MHz, d6-DMSO, for full spectrum see Fig. S12): δ 159.4, 122.6, 
106.7, 104.3, 103.4; HRMS (ESI) m/z calculated for C5H3NO2Br3 ([M+H]-) 345.7708, found 345.7674. 
 
Chemical synthesis of 3,4,5-tribromopyrrolyl-S-pantetheine probe 9 
 A synthetic scheme for 9 along with NMR spectra for intermediates and 2D NMR datasets for 9 are 
provided in the supplementary section (Figs. S13-S19). A flask was charged with previously prepared 7 (300 g, 
0.86 mmol, 1 equiv.) and CH2Cl2 (10 mL). Oxalyl chloride (0.15 mL, 1.7 mmol, 2 equiv.) was added slowly 
and the mixture was allowed to stir for 1 h. The solvent was removed and the residue was taken up in CH2Cl2 
(10 mL). N-Boc-2-amino ethanethiol (228 mg, 1.3 mmol, 1.5 equiv.) followed by triethylamine (0.24 mL, 1.7 
mmol, 2 equiv.) were added and the reaction was allowed to stir at ambient temperature overnight. After 
removal of the solvent, the residue was subjected to flash column chromatography (hexanes/EtOAc 9:1 → 4:1) 
to give the respective thioester (260 mg, 0.51 mmol, 59%). Rf 0.30 (hexanes/EtOAc 4:1); 1H-NMR (500 MHz, 
CDCl3, n.b.- Due to rotamers at the Boc carbamate, some peaks are split. NH peaks are not reported. A full 1H 
spectrum is given in Fig. S13): δ 3.45-3.14 (m, 3H), 2.78 (t, J = 6.6 Hz, 1H), 1.54-1.39 (m, 9H); HRMS (ESI) 
m/z calculated for C12H15N2O3SBr3Na ([M+Na]+) 526.8246, found 526.8210. To a solution of this thioester (260 
mg, 0.51 mmol) in EtOAc (4 mL) at 0 °C was added freshly prepared HCl in EtOAc (4 mL, 3 M in EtOAc)1. 
The solution was allowed to warm to ambient temperature and stirred for 15 min before use. The mixture was 
stirred at 0 °C for 30 min whereupon a white precipitate had formed. The solvent was removed under vacuum to 
afford hydrochloride salt S1 (quant.). A flask was charged with acetonide S2 (11) previously prepared (12) (64 
mg, 0.25 mmol, 1.1 equiv.) and EDC (66 mg, 0.35 mmol, 1.5 equiv.). A suspension of S1 (100 mg, 0.23 mmol, 
1 equiv.) in CH2Cl2 (2 mL) was added followed by diisopropylethylamine (80 µL, 0.46 mmol, 2 equiv.). The 
mixture was stirred at ambient temperature overnight. The solvent was evaporated and the residue was directly 
subjected to flash column chromatography (hexanes/EtOAc 1:1 → EtOAc) to afford to corresponding amide 
product (64 mg, 0.10 mmol, 43%). The acetonide (10 mg, 0.015 mmol) was dissolved in AcOH/H2O (1 mL, 
2:1), and the solution was stirred for 5 h. The mixture was poured into a separatory funnel containing sat. 
NaHCO3 and EtOAc. The phases were separated and the aqueous phase was extracted three times with EtOAc. 
The combined organic phases were washed with brine and dried over MgSO4. The solvent was removed and the 
residue was purified by flash column chromatographs (CH2Cl2/MeOH 20:1) to give diol 9: (7.5 mg, 0.012 
mmol, 80%) Rf 0.45 (CH2Cl2/MeOH 9:1); 1H-NMR (500 MHz, d6-DMSO): δ 8.16 (t, J = 5.7 Hz, 1H, NH), 7.70 
(t, J = 5.9 Hz, 1H, NH), 5.36 (bs, 1H), 4.45 (bs, 1H), 3.69 (s, 1H), 3.36-3.20 (m, 4H), 3.16 (d, J = 10.4 Hz, 1H), 
3.09 (t, J = 6.7 Hz, 1H), 2.31-2.22 (m, 2H), 0.79 (s, 3H), 0.77 (s, 3H); 13C-NMR (150 MHz, d6-DMSO): δ 
                                                 1 To a mixture of EtOAc (2.4 mL) and EtOH (0.72 mL) at 0 °C was slowly added AcCl (0.85 mL). 
178.9, 173.0, 170.8, 129.3, 109.9, 104.4, 104.0, 75.1, 68.2, 48.7, 39.1, 38.2, 35.2, 34.9, 21.0, 20.4; HRMS (ESI) 
m/z calculated for C16H22N3O5SBr3Na ([M+Na]+) 627.8723, found 627.8719. 
 
Preparation and purification of 3,4,5-tribromopyrrolyl-S-Bmp1(ACP) 8 and pyrrolyl-S-Mpy15 
E. coli CoA biosynthetic enzymes pantothenate kinase CoaA, phosphopantetheine adenyl transferase 
CoaD, and dephospho-CoA kinase CoaE were expressed and purified as previously described (12). To generate 
8, 10 reactions of 500 µL each consisting of 2 µM CoaA, 2 µM CoaD, 2 µM CoaE, 2 µM Sfp, 250 µM 
Bmp1(ACP), 1 mM 3,4,5-tribromopyrrolyl-S-pantetheine 9, 10 mM MgCl2, and 9 mM ATP in 50 mM HEPES 
(pH 7.9) buffer were incubated at 30ºC for 12 h. As a negative control, ATP was substituted with an appropriate 
volume of buffer in a single 100 µL scale reaction.  Reactions were pooled and purified by size exclusion 
chromatography on a Superdex 75 10/300 GL (GE Life Sciences) column eluted isocratically with 20 mM 
HEPES-Na (pH 7.5) 100 mM KCl. Glycerol was add to pooled fractions containing product to a final 
concentration of 10% (v/v) followed by concentration. An identical procedure was used for generation and 
purification of pyrrolyl-S-Mpy15 with Mpy15 switched for Bmp1(ACP) and 9 switch for pyrrolyl-S-pantetheine 
synthesized as previously reported (12). 
 
LC-MS/MS confirmation of chemo-enzymatically prepared pyrrolyl-S-ACPs  
Loading reactions were confirmed by LC/MS/MS as previously described (3). Reactions with and 
without ATP were injected onto a C4 column (Vydac 5 μm, 4.6 mm × 250 mm) operating on an Agilent 1260 
HPLC in tandem to an Agilent 6530 Accurate Mass Q-TOF mass spectrometer. Mass spectra were acquired in 
positive ionization mode. HPLC solvents used were water + 0.1% formic acid (A) and MeCN + 0.1% (B). The 
elution profile was as follows (flow rate: 0.7 mL/min): 10% B for 10 min, linear increase to 30% B over 5 min, 
linear increase to 70% B over 40 min, linear decrease to 10% B over 5 min, linear increase to 100% B over 1 
min followed by 2 min at 100% B, decrease to 10% B over 1 min, 10% B for 2 min and 5 min of post-time 
equilibration. Loading was assessed by extraction of the predicted acyl-(cylco)pantetheine MS2 fragments 
corresponding to the pantetheine arm of the holo-ACP as previously described (3). The mass and charge of the 
parent peptide were determined from the corresponding deconvoluted peptidic MS1 spectra, and the mass 
difference was confirmed between apo-ACP from the no ATP negative control and holo-ACP from the reaction 
with ATP (Fig. S3). 
 
In vitro enzymatic synthesis of 1 from 8 
1 mL reactions consisting of 25 µM 8, 50 mM KBr, 0.1 mM FAD, 2 mM NADP+, SsuE, PtdH, 10 mM 
phosphite, 50 µM Mm_Bmp2, and 25 µM Mm_Bmp1(TE) or Mm_Bmp1(TE):S202A for 12 h at 30 ºC in 
buffer consisting of 20 mM Tris-HCl (pH 8), 50 mM KCl, and 10% (w/v) glycerol. For reactions where 
enzymes were excluded (-Bmp2 and -TE) an equivalent volume of buffer was substituted. Reactions were 
extracted with 1.6 mL EtOAc. The organic layer was collected and solvent was removed in vacuo and the 
resulting residue was dissolved in 100 µL MeOH. Samples (30 µL injections) were analyzed by LC/MS/MS 
using the same conditions as described for in vivo and Mm_Bmp1-4 in vitro extracts. To ensure no carryover 
from one injection to the next, reactions were analyzed in the order ‘-Bmp2’, ‘-TE’, ‘S202A’, and ‘All’, with 
data gathered for blank injections preceding and following each reaction extract.   
 
Cloning, expression, purification, crystallization, and structure determination for Mm_Bmp2 and 
Mm_Bmp2-TM 
Cloning, expression, and purification. P. sp. PS-5 Bmp2 was cloned into the pET28b(+) (Novagen) 
plasmid vector utilizing the NdeI and XhoI restriction sites to afford a thrombin cleavable hexa-histidine tag at 
the N-terminus of the recombinant protein. Selection pressure was maintained by inclusion of 50 µg/mL 
kanamycin (final concentration) in all solid and liquid growth media. The insert was verified by restriction 
analysis and Sanger sequencing (SeqXcel, La Jolla, CA), and transformed in to E. coli BL21-Gold(DE3) 
(Agilent) cells for protein expression. 1 L terrific broth culture was grown to an OD600 ~ 0.6 at 30 ºC and 
protein expression was induced by the addition of IPTG to a final concentration of 0.3 mM. The temperature 
was adjusted to 18 ºC, and the culture was allowed to incubate for an additional 18 h. Cultures were harvested 
by centrifugation, the supernatant discarded, and the pellet resuspended in 20 mM Tris-HCl (pH 8.0), 500 mM 
NaCl, 10% glycerol buffer, and lysed by sonication. The supernatant was clarified by centrifugation and loaded 
on to a 5 mL His-Trap Ni-NTA column (GE Biosciences) equilibrated in harvest buffer. The column was 
extensively washed with 20 mM Tris-HCl (pH 8.0), 1 M NaCl, 30 mM imidazole buffer, and eluted by a linear 
gradient to 20 mM Tris-HCl (pH 8.0), 1 M NaCl, 200 mM imidazole buffer across 20 column volumes. Purity 
of eluted proteins was checked by SDS-PAGE, and thrombin was added to a final concentration of 1 unit/mg 
recombinant protein. Thus purified protein was then dialyzed overnight against 20 mM Tris-HCl (pH 8.9), 50 
mM KCl buffer at 4 °C. The dialyzed protein was applied to a 5 mL ion exchange Q Sepharose FF column (GE 
Biosciences) equilibrated in dialysis buffer, and eluted using a linear gradient to 20 mM Tris-HCl (pH 8.9), 1 M 
KCl buffer.  
Activity assays. For activity assays, protein was concentrated after ion exchange using Amicon 
centrifugal filters to a final volume of 2.5 mL and buffer was exchanged using PD-10 size exclusion columns 
(GE Biosciences) to 20 mM Tris-HCl (pH 8.0), 10% glycerol buffer. The protein concentration was measured 
using the Bradford assay, and protein was stored at -80 °C in 100 µL aliquots.  
Crystallization. For crystallization, 4 mL of ion exchange-purified protein was applied to a Sephadex-75 
size exclusion chromatography column (GE Biosciences) equilibrated in 20 mM HEPES-Na (pH 7.5), 100 mM 
KCl buffer and eluted isocratically. Protein purity was verified by SDS-PAGE, and pure fractions were pooled 
and concentrated using Amicon centrifugal filters to a final concentration of 100 µM. Sparse-matrix screening 
for crystal growth was performed using commercially available crystallization screens in hanging-vapor drop 
format at 9 °C. Initial conditions were optimized at 9 °C in hanging-vapor drop format to yield the following 
reproducible crystal growth condition for wild type Bmp2: 100 mM HEPES-Na (pH 7.5), 200 mM NaCl, 25% 
(w/v) PEG3350. Crystals appeared within 2 days and reached their maximum size by 5 days. The crystals were 
harvested and briefly dipped in 100 mM HEPES-Na (pH 7.5), 200 mM NaCl, 25% (w/v) PEG3350, 20% (v/v) 
ethylene glycol cryo-protectant prior to vitrification in liquid nitrogen. 
Structure determination. X-ray diffraction were scaled and indexed using the HKL-2000 package (13) 
and unit cell composition determined (14). Bmp2 structure was determined by molecular replacement using 
Phaser (15) by a sequence-alignment based Ala model (16) of the PDB: 3E1T (17). Initial solution was 
extended manually using Coot (18) and computationally using ARP/wARP (19) in an iterative manner. 
Refinement was carried out using Phenix (20). Although clear density for FAD could be observed prior to 
refinement, the cofactor was manually built into the model only after the free R factor (21) dropped below 30%. 
Mm_Bmp2-TM. Mm_Bmp2-TM was generated by PCR site-directed mutagenesis using bmp2-wt 
pET28b(+) plasmid vector as template. Mutations were verified using Sanger sequencing (SeqXcel, La Jolla, 
CA), and recombinant Mm_Bmp2-TM protein was expressed and purified in a manner identical to that 
described above. Mm_Bmp2-TM was prone to aggregation, and care was taken to minimize the time between 
purification and crystallization trials. Mm_Bmp2-TM crystallized in conditions similar to Bmp2-wt, albeit with 
different space group and unit cell dimensions, with the final optimized mother liquor being 100 mM HEPES-
Na (pH 7.5), 200 mM ammonium sulfate, 20% (w/v) PEG3350, 5% (v/v) ethylene glycol. Crystals were briefly 
dipped in 100 mM HEPES-Na (pH 7.5), 200 mM ammonium sulfate, 20% (w/v) PEG3350, 25% (v/v) ethylene 
glycol cryo-protectant prior to vitrification in liquid nitrogen. Structure of Mm_Bmp2-TM was determined 
using the structure of Bmp2-wt as a molecular replacement search model. 
 
Cloning, expression, purification, crystallization, and structure determination for Mpy16 
Cloning, expression, and purification. Mpy16 was amplified from the genomic DNA of Streptomyces 
CNQ-418 (22) and cloned into a modified pET28-MBP vector that we have described previously (23). This 
vector affords a N-terminal hexa-histidine tag, followed by a maltose binding protein (MBP), and a TEV 
protease cleavage site downstream of the MBP protein, followed by the translated recombinant protein. Culture 
growth conditions, and protein purification protocols are identical to those described above (TEV was used in 
place of thrombin to remove the purification tag), with an additional subtractive Ni-NTA chromatography step 
before ion exchange employed to remove the hexa-histidine bearing MBP tag subsequent to TEV digestion. 
Crystallization and structural determination. Initial crystallization conditions for Mpy16 were identified 
as before for Bmp2, and optimized to 100 mM Tris-HCl (pH 8.0), 10% (w/v) PEG8000, 5% (v/v) glycerol. The 
crystals were briefly dipped in 100 mM Tris-HCl (pH 8.0), 10% (w/v) PEG8000, 30% (v/v) glycerol cryo-
protectant prior to vitrification in liquid nitrogen. X-ray diffraction data was indexed and scaled as before for 
Bmp2, and molecular replacement solution identified using 3E1T as molecular replacement search model. 
Model building and refinement was carried out in a manner identical to that described above. 
 
Co-expression of Mm_bmp2 with Mm_bmp1, Mm_bmp3, and Mm_bmp4 
A two-plasmid system in E. coli BL21 Gold (DE3) for the coexpression of Mm_bmp1, Mm_bmp3, and 
Mm_bmp4 has been described previously for the in vivo production of pyrrolyl-S-Bmp1 (3). To this system was 
introduced a third plasmid, pETDuet (Novagen), bearing Mm_bmp2 or Mm_bmp2-TM in the second cloning site 
(MCS-2) of the plasmid vector. 5 mL LB liquid cultures were grown in the presence of 50 µg/mL kanamycin, 
50 µg/mL streptomycin, and 100 µg/mL ampicillin (final concentration) and supplemented with 1 g/L (final 
concentration) of KBr. At OD600 ~ 0.6, protein expression was induced by the addition of 0.3 mM IPTG 
(Promega, PAV3951) and growth was allowed at 30 °C for an additional 18 h. The culture was extracted twice 
with EtOAC and solvent removed in vacuo. The residue was dissolved in methanol, and analyzed LC/MS/MS 
as described previously. 
 
In vitro assay of wild type Mm_Bmp2, Mm_Bmp2-TM, and Mpy16 with pyrrolyl-S-ACPs as substrates  
 Pyrrolyl-S-Bmp1(ACP) and pyrrolyl-S-Mpy15 were prepared as described previously (12) and used as 
substrates in in vitro reactions. 50 µM pyrrolyl-S-ACP substrate was incubated with 20 µM halogenase catalyst 
in 20 mM HEPES-Na (pH 7.9) reaction buffer containing 200 mM halide (KCl or KBr), 1 mM NADP+, 20 µM 
FAD, 10 mM freshly made Na-phosphite, 5 mM TCEP, 10 µM PtdH and SsuE enzymes, and 10% v/v glycerol. 
Reactions were incubated at 30 C for 3 h, and 100 µL reaction was quenched by the addition of 50 µL of 2% 
formic acid. Precipitate was removed by centrifugation and assays analyzed by LC/MS/MS as reported 
previously (12). Abundance of acyl-(cyclo)pantetheine MS2 product ions were individually normalized for each 
assay as reported in Figures 6E–G. 
  
SUPPLEMENTARY FIGURES 
 
 
 
Figure S1. LC/MS comparisons of in vivo and in vitro EICSs to those of authentic standards of 1, 6, and 7. 
EICs for predicted [M-H]1- for the most abundant isotopic masses of 1 (m/z 381.67), 6 (m/z 301.76), and 7 (m/z 
345.75). All traces are self-normalized.  
 
 
Figure S2. Confirmation of CoA extension and loading of pyrrole substrates onto ACPs.  A. Scheme for 
CoA in vitro extension of chemically synthesized pyrrolyl-S-pantetheine precursor to pyrrolyl-S-CoA by E. coli 
CoA biosynthetic enzymes CoaA, CoaD, and CoaE. Upon completion of CoA synthesis, the substrate is loaded 
onto the catalytic serine of apo-ACP via B. subtilis phosphopantetheine transferase Sfp to generate “holo” 
pyrrolyl-S-ACP, resulting in a gain in mass specified to the right. To confirm substrate generation, the whole 
protein was analyzed by LC/MS/MS, resulting in a characteristic pantetheine MS2 fragments. Comparison to 
Apo-ACP from a negative control reaction in which ATP required for CoA enzymatic steps is excluded, 
demonstrates the expected mass shift between the parent ion and for apo- and holo- forms. B. i. MS1 and M2 
for apo-Mpy15, ii. MS1 and MS2 for pyrrolyl-S-Mpy15. Red diamonds indicated the MS1 peptide masses while 
blue diamonds indicated peptide mass sampled for MS2. The pantetheine fragment mass is indicated in the MS2 
spectrum. Charge is indicated to the right of the parent peptide. The corresponding mass shift between apo- and 
holo- Mpy15 is indicated by the dotted lines. C. Analogous scheme to ‘B’ for generation of 3,4,5-
tribromopyrrolyl-S-Bmp1(ACP) 8 from chemically synthesized 3,4,5-tribromopyrrolyl-S-pantetheine 9. 
 
 
 
Figure S3. Bioinformatic identification and in vitro confirmation of catalytic Ser202 of Mm_Bmp1(TE) 
with a model chromogenic substrate, p-nitrophenyl acetate (pNPA).  
A. i) Architecture of Bmp1 ACP-TE didomain, ii) BLAST query of the PDB database with the amino acid 
sequence of Mm_Bmp1 gives closest functionally and structurally characterized homolog CumD (44% 
similarity, 25% identity, 65% query coverage, e-value 7x10-14), a meta-cleavage product hydrolase from 
Pseudomonas fluorescens IP01 involved in the degradation cumene (isopropyl benzene); Bmp1:Ser202 aligns 
with confirmed catalytic Ser103 of CumD (24). B. 250 µM freshly prepared pNPA in 20 mM Tris-HCl (pH ~ 
8), 50 mM KCl, 10% (v/v) glycerol was incubated with 5 µM Bmp1(TE), Bmp1(TE):S202A, or no enzyme. 
Upon addition of fresh substrate in DMSO to the buffer solution, the reaction was monitored 
spectrophotometrically at wavelength of 400 nm in a plastic UV cuvette. Enzyme was added 5 minutes after 
addition of the substrate. Measured absorbance is plotted versus time. Upon addition of Bmp1(TE), a steep 
absorbance increase was observed due to production of hydrolysis product p-nitrophenol. Loss of hydrolytic 
activity, identical to incubation without enzyme (blue curve), was observed when pNPA was incubated with 
Bmp1(TE):S202A (black curve). 
  
 
 
Figure S4. Non-enzymatic hydrolysis of proposed ACP-bound tetrabrominated intermediate yields 1. 
Extracted ion chromatograms (EICs) for 2,3,4,5-tetrabromo-1H-pyrrole (m/z 381.67) from incubations of 3,4,5-
tribromopyrrolyl-S-ACP with various combination of Bmp1(TE) and Bmp2. All EICs are normalized to the 
largest peak (highlighted in green) in ‘Bmp1(TE):S202A’ EIC. Green highlight indicates presence of 1. LC/MS 
analyses were performed sequentially with blank runs before and after each run in order to discount carry-over 
of substrate. Only the first blank run is shown, as 1 was not observed in the ‘no Bmp2’ reaction, and levels 
increased in the subsequent reactions. B. Mass spectral pattern at location of the dashed line in A; ‘No 
Bmp1(TE)’ and ‘Bmp1(TE):S202A’ reactions show m/z and isotopic distribution consistent with 1. 
 
Figure S5. Interrogation of the potential of 2,3,4-tribromopyrrole 6 and 7 to serve as intermediates in the 
biosynthesis of 1. One mL reactions consisting of 25 µM 2 or 7 were incubated with 50 mM KBr, 0.1 mM 
FAD, 2 mM NADP+, SsuE, PtdH, 10 mM phosphite including or excluding 50 µM Bmp2 and 25 µM Bmp1(TE, 
78-376) in 20 mM Tris-HCl (pH 8) with 50 mM KCl and 10% (v/v) glycerol for 12 h at 30 ºC. Reactions were 
extracted with 1.6 mL EtOAc. Solvent was removed in vacuo and the resulting residue was dissolved in 100 µL 
MeOH. The extracts were analyzed by LC-MS/MS as previously described. A. Combined EICs for m/z 301.76 
(6) and m/z 381.67 (1) reactions with substrate 6 (highlighted in orange) with i) Bmp1(TE) ii) Bmp2, iii) Bmp2 
and Bmp1(TE), and iv) neither Bmp1(TE) nor Bmp2. Incomplete conversion to 1 (highlighted in green) was 
observed in ii)-iii). Mass spectra for products are shown above EICs for ii)-iii). All EICs are normalized to ‘i’. B. 
Combined EICs for m/z 345.75 (7) and m/z 381.67 (1) for reactions with 7 (highlighted in red) as substrate with 
i) Bmp2 and Bmp1(TE) and ii) neither Bmp2 nor Bmp1(TE). No conversion was observed. EICs are 
normalized to ‘i”.  
 
 
Figure S6. Reductive debromination of 1 by NADPH yields 6. A) EICs for 1 (m/z 381.67, shaded green) and 
6 (m/z 301.76, shaded orange) for the organic extracts of 1 mL reactions incubated in 20 mM Tris-HCl (pH 8) 
with 50 mM KCl and 10% (v/v) glycerol for 12 h at 30 ºC consisting of 50 µM 1 with 2 mM NADP+, 10 mM 
phosphite, and including or excluding PtdH (i.e., NADPH generation system with and without PtdH). (i) In the 
presence of the full NADPH generation system modest conversion of 1 to 6 is observed. (ii) When PtdH is 
eliminated from the reaction, no conversion of 1 to 6 is observed; NADP+ is not reduced to NADPH in the 
absence of PtdH. B) EICs for 1 (m/z 381.67, shaded green) and 6 (m/z 301.76, shaded orange) for the organic 
extracts of 1 mL reactions incubated in 20 mM Tris-HCl (pH 8) with 50 mM KCl and 10% (v/v) glycerol for 12 
h at 30 ºC consisting of 50 µM 1 with or without 1 mM NADPH. (i) In the presence of NADPH modest 
conversion of 1 to 6 is observed, consistent with the experiment shown in panel ‘A’ with the complete NADPH 
generation system. (ii) In the absence of NADPH no conversion of 1 to 6 is observed.  
 
 
Figure S7. FAD-bound holo structures of pyrrolyl-S-ACP flavin-dependent halogenases from this study. 
(A) holo-Mm_Bmp2 structure. (B) holo-Mpy16 structure. (C) Superimposed Bmp2 (in pink) and Mpy16 (in 
green) structures. The flavin cofactors and the side chain of the catalytic lysine residues are shown in stick-ball 
representation. 
  
  
 
Figure S8. Lack of chlorination activity for Bmp2-TM. Halogenation reactions for Bmp2-TM were carried 
out as before, but in the absence of bromide, and in the presence of 200 mM chloride in the reaction. As can be 
seen from the EICs, no mono-, di-, or tri-chlorinated pyrrolyl-S-Bmp1(ACP) products can be detected. 
  
 
 
 
 
Figure S9. In vivo coexpression of Mm_bmp1, Mm_bmp3, and Mm_bmp4 with wildtype Mm_bmp2 
(Mm_bmp2-wt) or Mm_bmp2 triple mutant (Mm_bmp2-TM). Combined extracted ion chromatograms at [M-
H]1- m/z 381.67 (1) and m/z 301.76 (6) corresponding to the dominant ions for the molecular formulae C4NHBr4 
and C4NH2Br3, respectively. Production of 1 and 6 can be observed when Mm_bmp2-wt is coexpressed with 
Mm_bmp1, Mm_bmp3, and Mm_bmp4, together with previously reported M. mediterranea MMB-1 
phosphopantetheinyl transferase (GenBank locus tag: NC_015276.1) (3). However, neither production of 1 nor 
6 is observed with bmp2-wt is substituted by Mm_bmp2-TM (expressing Bmp2-Y302S, F306V, A345W triple 
mutant). 
  
 
Figure S10. 1H NMR spectrum of 1 (CDCl3, 500 MHz). 
 
 
Figure S11. 1H NMR spectrum of 7 (CDCl3, 500 MHz). 
 
Figure S12. 13C NMR spectrum of 7 (CDCl3, 125 MHz). 
 
 
Figure S13. Scheme for the synthesis of 9. 
 
 
Figure S14. 1H NMR spectrum of Boc-protected S1 (CDCl3, 500 MHz). 
 
 
Figure S15. 1H NMR spectrum of 9 (d6-DMSO, 500 MHz). 
 
 
Figure S16. 13C NMR spectrum of 9 (d6-DMSO, 150 MHz). 
 
 
Figure S17. DQF-COSY spectrum of 9 (d6-DMSO, 600 MHz). 
 
 
Figure S18. HSQC spectrum of 9 (d6-DMSO, 600 MHz). 
 
 
Figure S19. HMBC spectrum of 9 (d6-DMSO, 600 MHz). 
 
 
Figure S20. Sequence alignments of Bmp2 homologs. Sequence alignment of Bmp2 homologs from 
Pseudoalteromonas sp. PS5 (PS5_Bmp2), Marinomonas mediterranea MMB-1 (Mm_Bmp2), 
Pseudoalteromonas sp. A757 (A757_Bmp2), Pseudoalteromonas luteoviolacea 2ta16 (2ta16_Bmp2), and 
Pseudoalteromonas phenolica O-BC30 (O-BC30_Bmp2) showing conservation of Y302, F306, and A345 
residues (numbering according to PS5_Bmp2 sequence). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
SUPPLEMENTARY TABLES 
 
Table S1. Bmp homology. 
Protein name Annotation PS5 X Mm 
(% amino acid 
similarity/ identity)  
PS5 X A757  
(% amino acid 
similarity/ identity) 
Bmp1 Acyl carrier protein(ACP)-thioesterase didomain 83/70 98/94 
Bmp2 FADH2-dependent pyrrolyl-S-ACP brominase 89/83 99/95 
Bmp3 FADH2-dependent prolyl-S-ACP dehydrogenase 84/76 97/93 
Bmp4 L-proline adenylation domain 67/51 93/85 
Bmp5 FADH2-dependent p-hydroxbenzoate 
brominase/decarboxylase 
No PS5 homolog 
found 
- 
Bmp6 Chorismate lyase No PS5 homolog 
found 
- 
Bmp7 Bromo- pyrrole/phenol coupling cytochrome P450 No PS5 homolog 
found 
- 
Bmp8 Carboxymuconolactone decarboxylase/peroxidase No PS5 homolog 
found 
- 
Bmp9 Ferredoxin 73/64 98/93 
Bmp10 Ferredoxin reductase 61/42 82/69 
 
  
Table S2. Data collection and refinement statistics for Mpy16, Bmp2, and Bmp2-TM structures.  
 Mpy16 Bmp2 Bmp2-TM 
Data collection    
Space group P21 21 21 P21 21 2 P21 
a, b, c (Å 62.83, 73.28, 189.72 82.97, 90.48, 57.92 49.23, 51.53, 77.06 
α, β, γ 90.00, 90.00, 90.00 90.00, 90.00, 90.00 90.00, 100.89, 90.00 
Rmerge (%) 0.09 (0.64) 1 0.08 (0.94) 0.06 (0.49) 
I/σ(I) 37.6 (3.0) 24.9 (1.9) 30.0 (8.5) 
Completeness (%) 100.0 (99.8) 100.0 (100.0) 98.8 (99.5) 
Total reflections 64779 36287 26147 
Redundancy 12.0 (11.7) 7.0 (7.0) 6.3 (5.9) 
    
Refinement    
Resolution (Å) 38.08 – 1.95 19.23 – 1.87 32.97 – 1.98 
Rwork/Rfree 0.172/0.212 0.188/0.224 0.179/0.215 
    
Number of atoms    
Protein 6825 3148 3096 
Solvent 428 274 219 
FAD 106 53 53 
    
Average B values    
Protein  31.53 27.75 26.00 
Solvent 35.77 33.99 31.77 
FAD 23.14 19.49 16.09 
    
R.m.s. deviations    
Bond lengths (Å) 0.007 0.007 0.007 
Bond angles (°) 1.036 1.097 1.085 
 
1Values for the highest resolution shell are reported in parentheses. 
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